SEC 13F Intelligence

Commerzbank Aktiengesellschaft /Fi / ABT

Commerzbank Aktiengesellschaft /Fi’s Abbott Laboratories Position

Does Commerzbank Aktiengesellschaft /Fi own Abbott Laboratories (ABT)? Yes — 117.2K shares worth $12M (+0.25% of its 13F portfolio) as of Q1 2026, up from 113.6K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
117.2K
% of Portfolio
+0.25%
Quarters Held
29
currently held

Position History ABT

Reported value by quarter
Q1 ’19: $29MQ1 ’19Q2 ’19: $34MQ3 ’19: $37MQ4 ’19: $27MQ1 ’20: $18MQ1 ’20Q2 ’20: $20MQ3 ’20: $25MQ4 ’20: $28MQ1 ’21: $35MQ1 ’21Q2 ’21: $37MQ3 ’21: $43MQ4 ’21: $54MQ1 ’22: $49MQ1 ’22Q2 ’22: $45MQ3 ’22: $41MQ4 ’22: $46MQ1 ’23: $44MQ1 ’23Q2 ’23: $51MQ3 ’23: $22MQ4 ’23: $25MQ1 ’24: $26MQ1 ’24Q2 ’24: $23MQ3 ’24: $26MQ4 ’24: $25MQ1 ’25: $28MQ1 ’25Q2 ’25: $31MQ3 ’25: $33MQ4 ’25: $14MQ1 ’26: $12MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026117.2K$12M+0.25%
Q4 2025113.6K$14M+0.29%
Q3 2025245.2K$33M+0.68%
Q2 2025224.3K$31M+0.70%
Q1 2025212.5K$28M+0.66%
Q4 2024223.5K$25M+0.61%
Q3 2024228.9K$26M+0.70%
Q2 2024220.4K$23M+0.76%
Q1 2024232.3K$26M+0.88%
Q4 2023225.9K$25M+0.99%
Q3 2023226.9K$22M+1.04%
Q2 2023469.1K$51M+2.51%
Q1 2023434.4K$44M+2.37%
Q4 2022418.7K$46M+2.87%
Q3 2022421.9K$41M+3.02%
Q2 2022415.9K$45M+3.16%
Q1 2022411.4K$49M+2.77%
Q4 2021384.0K$54M+3.07%
Q3 2021362.8K$43M+2.56%
Q2 2021320.5K$37M+2.36%
Q1 2021295.2K$35M+2.38%
Q4 2020257.3K$28M+2.14%
Q3 2020231.0K$25M+2.42%
Q2 2020217.9K$20M+2.12%
Q1 2020222.8K$18M+0.79%
Q4 2019305.4K$27M+0.26%
Q3 2019440.2K$37M+0.28%
Q2 2019399.6K$34M+0.27%
Q1 2019360.8K$29M+0.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commerzbank Aktiengesellschaft /Fi’s full portfolio or all institutional holders of ABT.